PHILADELPHIA – A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy , which is currently approved for five subtypes of blood cancer. Scientists in the Perelman School of Medicine at the University of Pennsylvania have demonstrated the potential efficacy of this approach in preclinical tests. In the study, published today in Science Translational Medicine , the researchers used engineered CAR T cells to target CD45—a surface marker found on nearly all blood cells, including nearly all blood cancer cells.

https://www.miragenews.com/car-t-cell-therapy-expansion-strategy-against-1075828/

#miragenews